Vol 44: Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474).Report as inadecuate



 Vol 44: Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474).


Vol 44: Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474). - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 44: Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474).
This article is from International Journal of Oncology, volume 44.AbstractProteasome inhibitors have been proven to be effective anticancer compounds in many tumor models, including glioblastoma multiforme (GBM). In this study, we found that the proteasome inhibitor Velcade (PS-341-bortezomib) caused GBM cell death while simultaneously activating t

Author: LIN, LEHANG; GAUT, DARIA; HU, KAISHUN; YAN, HAIYAN; YIN, DONG; KOEFFLER, H. PHILLIP

Source: https://archive.org/



DOWNLOAD PDF




Related documents